The relationships of the specific radioactivities of leucine in serum, leucine acylated to tRNA and leucine in procollagen I, procollagen III and total protein in lungs of unanaesthetized young male rats in vivo were assessed as a function of time during constant intravenous infusion of radiolabelled leucine. The specific radioactivity of free leucine in plasma reached a steady-state plateau value within 30 min of initiation of [3H]leucine infusion. Leucine acylated to tRNA isolated from lungs had the same specific radioactivity as free serum leucine. Leucine in procollagen I rapidly achieved a specific radioactivity equal to that of serum leucine and leucyl-tRNA, indicating that serum leucine and leucyl-tRNA isolated from total lung were in rapid equilibrium with the precursor leucine pool for procollagen I synthesis. On the basis of leucyl-tRNA or free serum leucine as the precursor, half-times of fractional conversion of procollagen I and III were calculated as 9 and 38 min respectively. The incorporation of leucine into mixed lung proteins calculated from the tracer studies was 6.8 pmol/day for the first 30min of the infusion, after which the calculated rate increased to 15.0umol/day. This apparent increase correlated with the appearance of rapidly labelled plasma proteins trapped in the lungs. On the basis of short infusions lasting 30min or less, followed by vascular perfusion of the lung, the average fractional synthesis rate of mixed pulmonary proteins in young male rats was 20%/day.
(Received 30 January 1984/Accepted I May 1984) The relationships of the specific radioactivities of leucine in serum, leucine acylated to tRNA and leucine in procollagen I, procollagen III and total protein in lungs of unanaesthetized young male rats in vivo were assessed as a function of time during constant intravenous infusion of radiolabelled leucine. The specific radioactivity of free leucine in plasma reached a steady-state plateau value within 30 min of initiation of [3H]leucine infusion. Leucine acylated to tRNA isolated from lungs had the same specific radioactivity as free serum leucine. Leucine in procollagen I rapidly achieved a specific radioactivity equal to that of serum leucine and leucyl-tRNA, indicating that serum leucine and leucyl-tRNA isolated from total lung were in rapid equilibrium with the precursor leucine pool for procollagen I synthesis. On the basis of leucyl-tRNA or free serum leucine as the precursor, half-times of fractional conversion of procollagen I and III were calculated as 9 and 38 min respectively. The incorporation of leucine into mixed lung proteins calculated from the tracer studies was 6.8 pmol/day for the first 30min of the infusion, after which the calculated rate increased to 15.0umol/day. This apparent increase correlated with the appearance of rapidly labelled plasma proteins trapped in the lungs. On the basis of short infusions lasting 30min or less, followed by vascular perfusion of the lung, the average fractional synthesis rate of mixed pulmonary proteins in young male rats was 20%/day.
The application of radiolabelled-tracer methodology for accurate measurement of rates of protein synthesis in tissues in vivo requires knowledge of the specific radioactivity of precursor amino acids for the proteins of interest. Under conditions of constant intravenous infusion of radioactive amino acids in rats (Waterlow et al., 1978) , constant specific radioactivities of serum amino acids and cellular amino acid precursors for protein synthesis can be maintained for several hours (Waterlow et al., 1978) . When it is found that the -measured specific radioactivities of tissue pools of free amino acids or amino acids acylated to tRNA are approximately equivalent to that of serum amino acids, the potential error of calculated rates of protein synthesis is small and the validity of the measurements relies only on the assumption that the measured precursor is homogeneous with respect to labelling and that the correct precursor Abbreviation used: SDS, sodium dodecyl sulphate. t To whom reprint requests should be addressed. has been chosen. This appears reasonable for tissues such as muscle, which are composed predominantly of one cell type and where average synthesis rates of total protein are measured (Waterlow et al., 1978) . However, for measurements of the synthesis of specific proteins in tissues composed of multiple cell types, where a small proportion of cells may be responsible for the synthesis of a particular protein, as in lung, this assumption may not be correct, as it is therefore desirable to define the relationship between the measured precursor isolated from the whole tissue and the precursor of the specific proteins being synthesized. The rapid turnover of type I collagen precursors (Robins, 1979) provides an experimental approach for testing whether or not this is a problem in the measurement of collagen synthesis, since an amino acid in procollagen proteins will achieve, in a relatively short period of time, a constant specific radioactivity equal to that of the amino acid in the precursor pool for this protein. Vol. 222 This proved to be the case in the present study for procollagen I in rat lung and permitted comparisons of the specific radioactivity of leucine in this protein with that of serum leucine and leucyltRNA isolated from the whole tissue. From (Brinkmann) for 2min at setting 3. The Polytron probe was rinsed with 5ml of SDS/cacodylic acid buffer for 15s, the rinse was added to the original homogenate, and the combined volumes were centrifuged for 5min at 10000g. The sample was mixed with an equal volume of re-distilled phenol/ SDS/cacodylic acid buffer (4: 1, v/v) and stirred for 15 min at room temperature. The mixture was centrifuged for 15min at 10000g, and the supernatant was carefully removed and stirred for 10min in the presence of 0.5vol. of phenol and centrifuged as above. The resultant supernatant was transferred to a 50 ml capped plastic centrifuge tube, 0.1 vol. of 20% (w/v) potassium acetate buffer, pH5.0, followed by 2.5vol. of cold 95% (v/v) ethanol, were added, and the mixture was allowed to precipitate at -20°C overnight.
The precipitate was collected by centrifugation at 4°C for 15 min at 1300g and washed twice with 95% ethanol. The precipitate was then flushed with N2 until dry, dissolved at 0°C in 3.5ml of acetate buffer (0.1 M-sodium acetate/0.01 M-magnesium acetate, pH4.0) and the solution centrifuged at 1000OOg for 1 h at 5°C. The supernatant was removed and tRNA precipitated by addition of 0.1 vol. of 20% potassium acetate, pH 5.0, followed by 2.5 vol. of 95% ethanol, and stored at -20°C overnight.
The tRNA was pelleted by centrifugation for 10min at 1000g. The pellet was washed once in 95% ethanol and dried. The tRNA was deacylated by the addition to the pellet of lO,I of 0.05M-NaHCO3, pH 9.0. The tube was capped and incubated at 37°C for 90min, after which 250pl of 95% ethanol was added and the sample was left for 1 h at -20°C. The sample was centrifuged for 10min at lOOOg and the supernatant removed for dansylation (5-dimethylaminonaphthalene-1-sulphonylation) of released amino acid. Amino acid specific radioactivity
The 3H specific radioactivity of leucine was determined in samples of protein hydrolysates and plasma free amino acids by using [1 4C]dansyl chloride binding and t.l.c., as previously described (Airhart et al., 1979 (Airhart et al., 1979) . Isolation ofprocollagens I and III Procollagens I and III were isolated and sequentially purified by differential salt precipitation, adherence to an anion-exchange resin, antibody affinity-column chromatography and polyacrylamide-gel electrophoresis (Byers et al., 1974; Smith et al., 1977) . All procedures were performed at 0-4°C. Weighed samples of powdered lung (as little as 100mg) stored at -70°C were thawed in lOml of procollagen-extracting buffer [150mM-NaCl, 50mM-Tris/HCI (pH 7.4)/20mM-EDTA/ 1 mM-p-chloromercuribenzoate/1 mM-phenylmethanesulphonyl fluoride/0.5% Triton X-100]. The tissue was ground in a Waring blender for 1 min and homogenized with a Polytron for 60 s at setting 3. The homogenate was stirred at 4°C for 30min, filtered through cheese-cloth, and centrifuged for 60min at 35000g. The precipitate was discarded and lipid was removed by suction. Procollagens were precipitated by slowly adding solid (NH4)2SO4 to 20% (w/v) and stirring overnight. The precipitate was collected by centrifugation for 1 h at 35000g and dissolved in 2ml of the original extracting buffer without Triton X-100. NaCl was then added slowly to 20% (w/v) with stirring. The extract was allowed to precipitate for 5 h and then centrifuged at 50000g for 35min. The precipitate was dissolved in 2ml of buffer [200mM-NaCI/50mM-Tris/HCl (pH 7.4)/1 mM-p-chloromercuribenzoate/1 mM-phenylmethanesulphonyl fluoride] and dialysed against the same buffer overnight. To remove non-collagenous acidic macromolecules, this solution was mixed with a slurry of DEAE-cellulose (DE 52, Whatman, Clifton, NJ, U.S.A.) previously equilibrated in the same buffer. The mixture was stirred for 30min and centrifuged at 7000g for IOmin. The supernatant was removed and pooled with the supernatant from a second wash of the resin. This supernatant was then dialysed for 8h against distilled water containing proteinase inhibitors and finally in antibodycolumn buffer [0.05M-Tris/HCl (pH7.5)/0.5M-NaCl] for 12h.
Procollagen species were further purified by affinity chromatography and gel electrophoresis. Antibodies to procollagen I were prepared in rabbits by a multiple injection schedule. Procollagens I and III could then be separated by applying the sample to an immunoadsorbent affinity column of CNBr-activated Sepharose coupled with dialysed rabbit antiserum to procollagen I. The column was washed sequentially with 20ml of column buffer [0.05M-Tris/HCI (pH 7.5)/0.5M-NaCI] to release procollagen III, its degradation products and other proteins, then with 20ml of eluting buffer [0.05 M-Tris/HCI (pH 7.5)/3mM-NaSCN] to release procollagen I and its immediate cleavage products PN aI, and once again with 20ml of column buffer. Pooled washes were dialysed overnight against distilled water and freeze-dried.
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Type-I and type-III collagen precursors were further purified by separation by SDS/polyacrylamide-gel electrophoresis. Electrophoresis was performed on 1.5mm-thick slab gels of 7.5% acrylamide by the method of Laemmli (1970) . The gel was stained with 0.25% Coomassie Brilliant Blue R, 50% (v/v) methanol/10% acetic acid for 90min and destained overnight in fresh 10% methanol/7.5% acetic acid. The bands containing procollagen I and procollagen III were identified (Robins, 1979) , cut from the gel, and washed briefly in three changes of distilled water for 20min each. Proteins were extracted overnight with 1 ml of 70% (v/v) formic acid with gentle shaking at room temperature. The procollagen-I and -III samples were dried in the SpeedVac, and hydrolysed overnight at 1 10°C in 6M-HCI (redistilled). The hydrolysates were dried, washed twice with distilled water, dried again, dissolved in 20*l of 0.1 M-NaHCO3 /Na2CO3 buffer (pH9) and made to react with [14C]dansyl chloride to determine the specific radioactivity of leucine (Airhart et al., 1979) .
Results
A typical curve for the rising specific radioactivity of free [3H]leucine in plasma is shown in Fig. 1 Thus a constant plateau plasma specific radioactivity was achieved within 15-25 min in all animals. After reaching a plateau value, the free leucine in plasma remained constant for as long as 2.5h. Fig. 2 shows the pattern of collagen precursors isolated from lung and separated on a SDS/7.5%-polyacrylamide gel. Type III collagen precursors were not retained on the type I collagen affinity column and appear in the initial wash (track a). Type I collagen precursors were released from the column during elution with NaSCN (track c). Procollagens I and III were identified, cut from the gel, and eluted for determination of specific radioactivity of leucine.
To assess the relationship between leucine free in plasma and intracellular pools involved in protein synthesis, we examined leucine specific radioactivity in procollagens and tRNA. The rise in specific radioactivity of peptidyl-leucine of purified procollagen I was rapid (Fig. 3) and achieved a value equivalent to the plasma plateau value during infusion studies lasting 45min or longer. Procollagen III turned over at a much slower rate and therefore its specific radioactivity failed to equilibrate with that of free leucine in plasma within 90min.
The relationship between the specific radioactivity of lung tRNA and the plateau value for plasma free leucine was determined in rats infused for 40min or longer (to allow accurate assessment of the plasma plateau). The specific radioactivity of leucine associated with tRNA of lung was 0.94 +0.06 (mean+ S.D., n = 6) of the free plasma leucine value. This agreement was achieved only when lungs were removed and immersed in liquid N2 within min of discontinuing the infusion. Delays of 1-2 min resulted in falls in specific radioactivity of leucyl-tRNA, to less than 40% of the plasma plateau value.
The agreement between specific-radioactivity determinations of leucyl-tRNA and procollagen I for infusions lasting 40min or longer (Fig. 4) Infusion time (min) Fig. 3 . Time course of specific radioactivity of leucine in lung procollagens I and III Data are plotted as specific radioactivity of procollagen divided by specific radioactivity of free leucine in plasma. Triangles represent specific radioactivity of leucine in procollagens (Pro) I (A) and III (A) in lungs of individual rats killed at different times during intravenous [3H]leucine infusions. The increase for procollagen I is rapid (half-time 9min), whereas procollagen III equilibrates with the specific radioactivity of plasma free leucine only after 90min (half-time 38min). Figure shows the patterns of collagen precursors isolated from lung and separated on a 7.5%-polyacrylamide slab gel. Individual fractions isolated by adherence to a procollagen I affinity column are shown. Track (a) shows type III collagen precursors which are not retained on the column. Track (b) demonstrates the absence of proteinaceous material after extensive washing of the column with neutral buffer. Track (c) contains the type I collagen precursor fraction, which is eluted from the column with NaSCN. Collagen precursors were identified with reference to previously published electrophoretic patterns (Robins, 1979) . The locations of a 1(I), a2(I), dimers and bovine serum albumin (BSA) on the same gel are indicated. Pro, procollagen; Poal(III), procollagen III intermediates; Pcacl(I)m type-I-collagen precursor containing C-terminal extension peptides.
[3H]leucine incorporation calculated as d.p.m./ lung was divided by the specific radioactivity of the precursor to yield a mass-based proteinsynthesis rate. The precursor specific radioactivity used in this calculation was a time-weighted plasma value based on eqn. (1) (see the Experimental section) to reflect the mean precursor Procollagen I (d.p.m./pmol) Fig. 4 . Relationship between leucyl-tRNA and procollagen I The specific radioactivity of leucyl-tRNA is compared with the leucine specific radioactivity of purified procollagen I for infusions lasting 30min or longer. Because soluble procollagen I has a small intracellular pool in lung, its leucine specific radioactivity quickly equilibrates with its precursors and validates the tRNA measurements. Each point represents data from a single animal; continuous line indicates linear regression [S(tRNA) = 1.08-S(proI)-2.27; r2 = 0.91, P<0.01] where S represents specific radioactivity of leucine.
Vol. 222 We chose leucine for these studies because it is an essential amino acid in the rat, gives a steep rise to plateau in plasma (Fig. 1) , and has been shown to equilibrate with the tissue free pool and tRNA in other tissues without the need to increase the concentration of leucine in plasma and tissue above normal values (Everett et al., 1981) . Although the leucine content of procollagen is low, we had no difficulty measuring the specific radioactivity of leucine in purified procollagens I and III from as little as 100mg of wet lung tissue.
The kinetics of the rise of specific radioactivity of free leucine in plasma were adequately rapid to provide a constant plateau value within 15-25 min (Fig. 1) , somewhat more rapid than reported by others (Everett et al., 1981) . The close agreement between the specific radioactivities of leucine free in plasma and associated with tRNA of lung indicates that these two compartments are in equilibrium. The correctness of the tRNA determinations is further corroborated by measurements of specific radioactivity of rapidly turningover procollagen I of lung, which almost exactly parallel the tRNA measurements (Fig. 4) .
Amino acids of extremely rapidly turning-over proteins such as procollagen I achieve specific radioactivities comparable with the plateau values for free amino acid in plasma (Robins, 1979) . If the protein product can be observed to reach the same specific radioactivity as the extracellular precursor, then both of these values must be equal to the specific radioactivity of leucyl-tRNA. The finding that lung leucyl-tRNA and free leucine of plasma reached equivalent specific radioactivities suggests that the majority of the cells in lung derive their leucine for protein synthesis exclusively from the extracellular fluid or from a compartment which rapidly equilibrates with it. This observation contrasts with several other experimental observations in cell-culture systems and whole animals, where certain amino acids used for protein synthesis may be derived primarily from protein breakdown, from sequestered intracellular pools, or from newly synthesized amino acids (Hildebran et al., 1981) .
The half-time for procollagen I turnover was calculated by the method suggested by Robins (1979) , based on the formula: SI = Sp (I +0.05 e-k-1.05e-kit) where S, is the specific activity of procollagen I, Sp is the free plasma leucine specific radioactivity, and kp and k, are the time constants (InO.5/ti) for the rise in specific radioactivity associated with leucine in plasma and procollagen I respectively.
From studies in ten animals, k1 was calculated to be 0.077min', with a corresponding half-time of 9min. This half-time of procollagen I conversion into smaller collagen precursor forms is considerably more rapid than has been calculated in skin by using somewhat different approaches to radiolabelling techniques. From 2 h infusions of labelled proline, Robins (1979) calculated a half-time of
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.82 26min in young rabbits, but pointed out that the actual time required for procollagen I conversion might be shorter than his estimate. Our estimate for the half-time of procollagen I conversion (9min) is in close agreement with the known time for procollagen-chain elongation of 6 min as determined in cultured calvarium (Vuust & Piez, 1972) and estimates of secretion time of 10-20min (Kao et al., 1977) . If chain elongation and secretion times are comparable in the rat lung, then procollagen I cleavage must occur close to the time of secretion.
The observation that procollagen III turnover is slower than that of procollagen I parallels similar observations in skin of growing rabbits (Robins, 1979) . A comparably slower procollagen III turnover also occurs in lung in the rat (half-time 38 min). This observation suggests that the pool of procollagen III is large relative to its synthesis rate, with a proportionately decreased fractional conversion rate by procollagen peptidase (Robins, 1979) . One might hypothesize alternatively that most of the procollagen III is produced in a small subpopulation of cells in which leucyl-tRNA is slower to equilibrate with plasma leucine. The exact cell population in lung responsible for type-III collagen synthesis has yet to be anatomically defined and isolated. Quantitative morphometric analyses have indicated that fibroblasts make up 52% of the interstitial cells of the rat lung (Crapo et al., 1980) . These cells are capable of simultaneous synthesis of both types I and III collagen in culture as well as in vivo (Gay et al., 1976) .
We found that measurements of protein turnover in lung by using prolonged exposure to radiolabelled precursor amino acids present some special problems not encountered in similar studies in other tissues. Both the high ratio of vascular volume to tissue in the lung and the rapid flux of vascular proteins (Wangensteen et al., 1983) through the interstitial compartment and lymphatics confound measurements of the true lung protein-synthesis rate. Several experimental observations are consistent with the suggestion that rapidly labelled serum proteins, notably albumin, confound measurements of protein turnover in the lung. In this regard we noted that, when constant intravenous infusions are allowed to proceed for longer than 25-30min, 3H-labelled albumin and other proteins begin to appear in plasma and can be rapidly detected in crude lung homogenates (results not shown). Because intravascular albumin turnover exceeds 750 0/day (Jeejeebhoy et al., 1972) , this source of exogenous labelled protein quickly begins to raise the apparent lung protein-synthesis rate.
Nevertheless, even when only brief infusions are considered, it is apparent that protein turnover as reflected by the fractional synthesis rate is far in excess of growth requirements of the tissue. The protein content of lungs of 200g animals, for instance, increases at 0.8%/day (results not shown). Thus most of the protein synthesis in the lungs of young male rats is directed toward turnover rather than tissue growth.
The FSR of lung protein calculated in these studies (0.20day-1) agrees with values determined in perfused isolated lungs. Watkins et al. (1983) found a FSR of0.20 day-1 by perfusing [3H]phenylalanine in rat lungs in situ. However, other measurements of lung protein-synthesis rates made in nonanaesthetized small animals have indicated higher values, in excess of 0.3 day-1 Laurent, 1982) .
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